Stockscreener 앱 받기
23.52
0.34%
-0.08
시간 외 거래:
24.88
1.36
+5.78%
전일 마감가:
$23.60
열려 있는:
$23.41
하루 거래량:
2.46M
Relative Volume:
1.20
시가총액:
$2.89B
수익:
$643.81M
순이익/손실:
$-490.76M
주가수익비율:
-5.7931
EPS:
-4.06
순현금흐름:
$-299.27M
1주 성능:
+7.94%
1개월 성능:
+6.14%
6개월 성능:
+24.58%
1년 성능:
-17.96%
1일 변동 폭
$23.27
$24.10
1주일 범위
$21.28
$24.32
52주 변동 폭
$15.81
$37.04
가든트헬스 Stock (GH) Company Profile
명칭
Guardant Health Inc
전화
855-698-8887
주소
3100 HANOVER STREET, PALO ALTO
가든트헬스 Stock (GH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-14 | 개시 | Guggenheim | Neutral |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-03-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-11-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 개시 | Craig Hallum | Buy |
| 2022-10-06 | 개시 | Stephens | Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-04-28 | 재개 | BTIG Research | Buy |
| 2022-02-24 | 재확인 | Canaccord Genuity | Buy |
| 2022-02-24 | 재확인 | Citigroup | Buy |
| 2022-02-24 | 재확인 | Cowen | Outperform |
| 2022-02-24 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-24 | 재확인 | SVB Leerink | Outperform |
| 2022-02-24 | 재확인 | Stifel | Buy |
| 2022-02-24 | 재확인 | Wells Fargo | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-11 | 개시 | Stifel | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-06-12 | 개시 | BTIG Research | Buy |
| 2020-02-21 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-08-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-16 | 개시 | Canaccord Genuity | Buy |
| 2019-04-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 재확인 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | JP Morgan | Overweight |
| 2018-10-29 | 개시 | William Blair | Outperform |
모두보기
가든트헬스 주식(GH)의 최신 뉴스
Unveiling Guardant Health (GH) Q3 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance
Guardant Health Inc (GH) Shares Up 5.61% on Nov 4 - GuruFocus.com
abrdn plc Raises Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
How To Trade (GH) - Stock Traders Daily
Guardant Health to Participate in Upcoming Investor Conferences - StockTitan
Guardant Health (GH) Stock Surges on Innovative Product Recognition - GuruFocus.com
Why Guardant Health Stock Was the Picture of Health Today - MSN
Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Guardant Health Named to TIME’s List of the Best Inventions of 2024 - The Bakersfield Californian
Guardant Health (GH) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Guardant Health (NASDAQ:GH) Trading Up 6.4%What's Next? - MarketBeat
GHGuardant Health, Inc. Latest Stock News & Market Updates - StockTitan
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024 - Business Wire
Companion Diagnostics Market to Enjoy 'Explosive Growth' to 2032| Biogenex Laboratories, Guardant Health, Abnova - openPR
Liquid Biopsy Market Size, Share, Growth Insights and Report - openPR
Guardant Health, Inc. (NASDAQ:GH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
An Intrinsic Calculation For Guardant Health, Inc. (NASDAQ:GH) Suggests It's 44% Undervalued - Simply Wall St
Guardant Health names new board member - Investing.com India
Where Does Wall Street Think Guardant Health Inc (GH) Stock Will Go? - InvestorsObserver
Roberto A. Mignone Joins Guardant Health Board of Directors - 01Net
Guardant Health names new board member By Investing.com - Investing.com UK
Guardant Health, Inc. Appoints Roberto Mignone. as Class I Director - Marketscreener.com
(GH) Trading Signals - Stock Traders Daily
Is There An Opportunity With Guardant Health, Inc.'s (NASDAQ:GH) 43% Undervaluation? - Yahoo Finance
Guardant Health (GH) Shares Decline Amid Market Volatility - GuruFocus.com
Guardant Health Inc (GH) Stock Price Down 3.84% on Oct 17 - GuruFocus.com
Leerink Partners Cuts Guardant Health (NASDAQ:GH) Price Target to $50.00 - MarketBeat
Can This Beaten-Down Cathie Wood Stock Bounce Back? - The Motley Fool
Quinn Emanuel client sanctioned over expert testimony - Daily Journal
Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024 - BioSpace
Short Interest in Guardant Health, Inc. (NASDAQ:GH) Rises By 20.6% - MarketBeat
4 Cancer Stocks to Consider in 2024 - The Motley Fool
Learn to Evaluate (GH) using the Charts - Stock Traders Daily
SG Americas Securities LLC Invests $1.03 Million in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Quinn Emanuel concedes expert's errors, says punishment unwarranted - Daily Journal
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market 2024: - openPR
Guardant Health Enters Oversold Territory (GH) - Nasdaq
Behind the Bell: Guardant Health - Nasdaq
Sei Investments Co. Takes $831,000 Position in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Deep Track Capital, LP Increases Stake in Guardant Health Inc - GuruFocus.com
45,267 Shares in Guardant Health, Inc. (NASDAQ:GH) Acquired by Thrivent Financial for Lutherans - MarketBeat
Lawyers say opponents are lying, judge calls one a fool in DNA test dispute - Daily Journal
Guardant Health, Inc. (NASDAQ:GH) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients - Nature.com
(GH) Long Term Investment Analysis - Stock Traders Daily
FDA approves first blood test screening for colon cancer - MSN
Canada Pension Plan Investment Board Invests $303,000 in Guardant Health, Inc. (NASDAQ:GH) - Defense World
Guardant Health’s stock up after FDA approves its blood test for colon-cancer screening - MSN
Scientech Research LLC Buys New Shares in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
7,652 Shares in Guardant Health, Inc. (NASDAQ:GH) Bought by Commonwealth Equity Services LLC - Defense World
가든트헬스 (GH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.48%
0.04%
자본화:
|
볼륨(24시간):